Bilirubin tests as risk predictors for systemic lupus...

Details Bilirubin tests as risk predictors for systemic lupus... Bilirubin tests as risk predictors for systemic lupus...

2005-06-14

2005-06-14

Wallenhorst, Maureen M. (Department: 1743)

Chemistry: analytical and immunological testing

Heterocyclic carbon compound

Hetero-n

C436S063000

Reexamination Certificate

active

06905880

ABSTRACT:
A new method for predicting the risk of cancer morality, rheumatoid arthritis; systemic lupus erythematosus, psoriatic arthritis, and all-cause mortality is disclosed. The method uses serum bilirubin levels as indicator for such risks, lower serum bilirubin levels generally indicating increased risk and higher levels a decreased risk.

REFERENCES:
patent: 5380667 (1995-01-01), Schwertner
patent: 6720189 (2004-04-01), Schwertner et al.
Jones et al. Ann. Rheum. Dis. vol. 59, 2000, pp. 904-909.
Manzi et al., Lupus, vol. 9, 2000, pp. 176-182.

Affiliated with

Also associated with

Rating

Bilirubin tests as risk predictors for systemic lupus... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bilirubin tests as risk predictors for systemic lupus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bilirubin tests as risk predictors for systemic lupus... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3476482